Text Size

Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects

This study has been completed.
Sponsor:
Information provided by:
Skane University Hospital
ClinicalTrials.gov Identifier:
NCT01029327
First received: December 8, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted
  Purpose

Previous animal studies have shown that extracts of Curcumin lowers blood glucose.


Condition
Diabetes

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Cross-Sectional

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Skane University Hospital:

Study Start Date: June 2009
Study Completion Date: September 2009
Groups/Cohorts
Healthy subjects

Detailed Description:

To study the effect of curcumin on postprandial blood glucose and plasma concentrations of insulin in fifteen healthy subjects.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy subjects recruited from the population in southern Sweden.

Criteria

Inclusion Criteria:

  • Fifteen healthy subjects without symptoms or a history of gastrointestinal disease, abdominal surgery or diabetes mellitus, were included in this crossover study.

Exclusion Criteria:

  • Connective tissue disease or cerebrovascular or endocrine disease.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01029327

Locations
Sweden
Department of Medicine, Malmö University Hospital
Malmö, Sweden, 205 02
Sponsors and Collaborators
Skane University Hospital
  More Information

No publications provided by Skane University Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

ClinicalTrials.gov Identifier: NCT01029327     History of Changes
Other Study ID Numbers: 353/2008c
Study First Received: December 8, 2009
Last Updated: December 8, 2009
Health Authority: Sweden: Regional Ethical Review Board

ClinicalTrials.gov processed this record on June 18, 2013